Terms and Conditions
Thank you for choosing CellMosaic’s products and services.
More than one set of terms may apply if your order includes different types of products or services. Please review the terms applicable to each item in your order.
By submitting an order, accepting a Quote, or otherwise authorizing CellMosaic to begin work, you acknowledge that you have reviewed and agree to the applicable terms and conditions.
Products and Kits
General Terms and Conditions for Sales of Products ↗
Custom Bioconjugation Services, Including Routine Synthesis™, HPLC Analysis, MS Analysis, and Other Bioanalytical or Bioassay Services
General Terms and Conditions for Custom Services ↗
Custom Bioconjugation Services Using CellMosaic Proprietary Technology
The following documents apply to custom bioconjugation services using CellMosaic Proprietary Technology, including services for:
- assay or diagnostic research, development, evaluation, and validation; and
- limited therapeutic feasibility and proof-of-concept studies.
General Terms and Conditions for Custom Services ↗ and the Proprietary Technology Addendum ↗
“Proprietary Technology” means AqT®, NeIon™, oxLink™, sxLink™, and any other CellMosaic linker, reagent, platform, method, process, know-how, material, or technology that the applicable Quote, Routine Synthesis Order, service page, or order confirmation expressly identifies as proprietary or subject to commercial-use restrictions.
Therapeutic development beyond the feasibility and proof-of-concept activities permitted under the Proprietary Technology Addendum requires a separate written collaboration or license agreement.
Pharmaceutical Drug-Development and Manufacturing Services
For bioconjugate drug-development or manufacturing services using classical or other nonproprietary linkers, including projects involving Customer-provided molecules or payloads, please contact CellMosaic to request a copy of the applicable Pharmaceutical Custom Services Terms.
For projects using CellMosaic Proprietary Technology that extend beyond permitted Therapeutic Feasibility Studies—including formal toxicology, IND-enabling development, regulatory submissions, clinical development or clinical trials, clinical or GMP manufacturing, or commercialization—please contact CellMosaic to discuss a separate written collaboration or license agreement.
The separate agreement may address development responsibilities, technology transfer, manufacturing and supply, field and territory, exclusivity, development milestones, diligence, regulatory responsibilities, patent rights, sublicensing, fees, royalties, quality requirements, and other applicable terms.